Cargando…

Correction to: Potent Neutralizing Activity of Polyclonal Equine Antibodies Against Severe Acute Respiratory Syndrome Coronavirus 2 Variants of Concern

Detalles Bibliográficos
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2022
Materias:	Correction
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10093067/ https://www.ncbi.nlm.nih.gov/pubmed/36130225 http://dx.doi.org/10.1093/infdis/jiac374

Ejemplares similares

Potent Neutralizing Activity of Polyclonal Equine Antibodies Against Severe Acute Respiratory Syndrome Coronavirus 2 Variants of Concern
por: Luczkowiak, Joanna, et al.
Publicado: (2022)

A Potent Recombinant Polyclonal Antibody Therapeutic for Protection Against New Severe Acute Respiratory Syndrome Coronavirus 2 Variants of Concern
por: Wayham, Nicholas P, et al.
Publicado: (2023)

Polyclonal F(ab’)(2) fragments of equine antibodies raised against the spike protein neutralize SARS-CoV-2 variants with high potency
por: Cunha, Luis Eduardo R., et al.
Publicado: (2021)

Inhibition of infection caused by severe acute respiratory syndrome-associated coronavirus by equine neutralizing antibody in aged mice()
por: Zhou, Lili, et al.
Publicado: (2007)

Correction: IgM antibodies derived from memory B cells are potent cross-variant neutralizers of SARS-CoV-2
por: Hale, Malika, et al.
Publicado: (2022)

Publisher Correction: A potent neutralizing antibody with therapeutic potential against all four serotypes of dengue virus
por: Xu, Meihui, et al.
Publicado: (2018)

Equine Polyclonal Antibodies Prevent Acute Chikungunya Virus Infection in Mice
por: Barker, Douglas, et al.
Publicado: (2023)

Structural Basis for Potent Neutralization of Betacoronaviruses by Single-Domain Camelid Antibodies
por: Wrapp, Daniel, et al.
Publicado: (2020)

Author Correction: Hapten-mediated recruitment of polyclonal antibodies to tumors engenders antitumor immunity
por: Schrand, Brett, et al.
Publicado: (2021)

IgG-like bispecific antibodies with potent and synergistic neutralization against circulating SARS-CoV-2 variants of concern
por: Chang, Matthew R., et al.
Publicado: (2022)

Correction: A vesicular stomatitis virus-based prime-boost vaccination strategy induces potent and protective neutralizing antibodies against SARS-CoV-2
por: Kim, Gyoung Nyoun, et al.
Publicado: (2022)

Author Correction: Titers of antibodies against ancestral SARS-CoV-2 correlate with levels of neutralizing antibodies to multiple variants
por: Tran, Trung The, et al.
Publicado: (2023)

Production of Potent Fully Human Polyclonal Antibodies against Ebola Zaire Virus in Transchromosomal Cattle
por: Dye, John M., et al.
Publicado: (2016)

Structure-selected RBM immunogens prime polyclonal memory responses that neutralize SARS-CoV-2 variants of concern
por: Almanza, Gonzalo, et al.
Publicado: (2022)

Prevalence of serum and salivary virus-neutralizing antibodies against equine coronavirus in four riding stables in Japan
por: BANNAI, Hiroshi, et al.
Publicado: (2023)

Monobodies with potent neutralizing activity against SARS-CoV-2 Delta and other variants of concern
por: Kondo, Taishi, et al.
Publicado: (2022)

High Efficacy of Therapeutic Equine Hyperimmune Antibodies Against SARS-CoV-2 Variants of Concern
por: Moreira-Soto, Andres, et al.
Publicado: (2021)

Mode of neutralization of lactate dehydrogenase-elevating virus by polyclonal and monoclonal antibodies
por: Plagemann, P. G. W., et al.
Publicado: (1992)

Nasal Spray of Neutralizing Monoclonal Antibody 35B5 Confers Potential Prophylaxis Against Severe Acute Respiratory Syndrome Coronavirus 2 Variants of Concern: A Small-Scale Clinical Trial
por: Lin, Yao, et al.
Publicado: (2022)

Isolation of a panel of ultra-potent human antibodies neutralizing SARS-CoV-2 and viral variants of concern
por: Gorchakov, Andrey A., et al.
Publicado: (2021)

Bispecific antibodies targeting distinct regions of the spike protein potently neutralize SARS-CoV-2 variants of concern
por: Cho, Hyeseon, et al.
Publicado: (2021)

SARS-CoV-2 variants show resistance to neutralization by many monoclonal and serum-derived polyclonal antibodies
por: Diamond, Michael, et al.
Publicado: (2021)

A highly potent antibody effective against SARS-CoV-2 variants of concern
por: Fenwick, Craig, et al.
Publicado: (2021)

Correction: Triple Immunoglobulin Gene Knockout Transchromosomic Cattle: Bovine Lambda Cluster Deletion and Its Effect on Fully Human Polyclonal Antibody Production
Publicado: (2014)

A Potent and Protective Human Neutralizing Antibody Against SARS-CoV-2 Variants
por: Shan, Sisi, et al.
Publicado: (2021)

Correction: Kurpas et al. Genomic Analysis of SARS-CoV-2 Alpha, Beta and Delta Variants of Concern Uncovers Signatures of Neutral and Non-Neutral Evolution. Viruses 2022, 14, 2375
por: Kurpas, Monika Klara, et al.
Publicado: (2023)

A novelly designed protein antagonist confers potent neutralization against SARS-CoV-2 variants of concern
por: Lv, Panjing, et al.
Publicado: (2022)

Correction to: Evaluation of serological lateral flow assays for severe acute respiratory syndrome coronavirus-2
por: Trombetta, Bianca A., et al.
Publicado: (2021)

Correction: Broad dengue neutralization in mosquitoes expressing an engineered antibody
por: Buchman, Anna, et al.
Publicado: (2020)

Assays for the assessment of neutralizing antibody activities against Severe Acute Respiratory Syndrome (SARS) associated coronavirus (SCV)
por: Wang, Shixia, et al.
Publicado: (2005)

Potent neutralization of SARS-CoV-2 variants of concern by an antibody with an uncommon genetic signature and structural mode of spike recognition
por: Kramer, Kevin J., et al.
Publicado: (2021)

A Bispecific Antibody Targeting RBD and S2 Potently Neutralizes SARS-CoV-2 Omicron and Other Variants of Concern
por: Yuan, Mengqi, et al.
Publicado: (2022)

Correction: Middle East Respiratory Syndrome Coronavirus Intra-Host Populations Are Characterized by Numerous High Frequency Variants
por: Borucki, Monica K., et al.
Publicado: (2016)

Development of Polyclonal Antibody against Clenbuterol for Immunoassay Application
por: Talib, Nurul Ain A., et al.
Publicado: (2018)

Correction: The Effects of Somatic Hypermutation on Neutralization and Binding in the PGT121 Family of Broadly Neutralizing HIV Antibodies
por: Sok, Devin, et al.
Publicado: (2013)

The Genomic Landscape of Severe Acute Respiratory Syndrome Coronavirus 2: Surveillance of Variants of Concern
por: Malick, M. Shaheen S., et al.
Publicado: (2021)

An evolutionary insight into Severe Acute Respiratory Syndrome Coronavirus 2 Omicron variant of concern.
por: Paz, Mercedes, et al.
Publicado: (2022)

Longitudinal Isolation of Potent Near-Germline SARS-CoV-2-Neutralizing Antibodies from COVID-19 Patients
por: Kreer, Christoph, et al.
Publicado: (2020)

Potent neutralizing monoclonal antibodies against Ebola virus infection
por: Zhang, Qi, et al.
Publicado: (2016)

Discriminating cross-reactivity in polyclonal IgG1 responses against SARS-CoV-2 variants of concern
por: van Rijswijck, Danique M. H., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_g4o21u5qh3arsbjf8beg1oc15j